Journey Advisory Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $795K | Buy |
7,400
+500
| +7% | +$53.7K | 0.06% | 174 |
|
|
2025
Q1 | $696K | Sell |
6,900
-1,950
| -22% | -$197K | 0.06% | 173 |
|
|
2024
Q4 | $682K | Hold |
8,850
| – | – | 0.08% | 129 |
|
|
2024
Q3 | $682K | Hold |
8,850
| – | – | 0.08% | 129 |
|
|
2024
Q2 | $682K | Sell |
8,850
-3,875
| -30% | -$298K | 0.08% | 129 |
|
|
2024
Q1 | $872K | Hold |
12,725
| – | – | 0.11% | 121 |
|
|
2023
Q4 | $736K | Sell |
12,725
-80
| -0.6% | -$4.63K | 0.1% | 122 |
|
|
2023
Q3 | $676K | Buy |
12,805
+3,875
| +43% | +$205K | 0.1% | 125 |
|
|
2023
Q2 | $483K | Hold |
8,930
| – | – | 0.07% | 149 |
|
|
2023
Q1 | $447K | Buy |
8,930
+500
| +6% | +$25K | 0.07% | 157 |
|
|
2022
Q4 | $390K | Sell |
8,430
-2,850
| -25% | -$132K | 0.1% | 151 |
|
|
2022
Q3 | $437K | Sell |
11,280
-1,220
| -10% | -$47.3K | 0.11% | 151 |
|
|
2022
Q2 | $513K | Buy |
+12,500
| New | +$513K | 0.12% | 147 |
|
|
2022
Q1 | – | Sell |
-5,000
| Closed | -$212K | – | 219 |
|
|
2021
Q4 | $212K | Hold |
5,000
| – | – | 0.06% | 201 |
|
|
2021
Q3 | $217K | Sell |
5,000
-500
| -9% | -$21.7K | 0.07% | 186 |
|
|
2021
Q2 | $235K | Hold |
5,500
| – | – | 0.07% | 186 |
|
|
2021
Q1 | $213K | Buy |
+5,500
| New | +$213K | 0.07% | 186 |
|